ZNF670
Zinc finger protein 670
Also known as: MGC12466, ZN670_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BS34
- Gene
- ZNF670
- Ensembl
- ENSG00000277462
- Chromosome
- 1
- Canonical length
- 389 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Acts upstream of or within lipid metabolic process. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
389 residues, UniProt reviewed canonical sequence.
>Q9BS34|ZNF670
1 MDSVSFEDVA VAFTQEEWAL LDPSQKNLYR DVMQEIFRNL ASVGNKSEDQ NIQDDFKNPG
61 RNLSSHVVER LFEIKEGSQY GETFSQDSNL NLNKKVSTGV KPCECSVCGK VFICHSALHR
121 HILSHIGNKL FECEECPEKL YHCKQCGKAF ISLTSVDRHM VTHTSNGPYK GPVYEKPFDF
181 PSVFQMPQST YTGEKTYKCK HCDKAFNYSS YLREHERTHT GEKPYACKKC GKSFTFSSSL
241 RQHERSHTGE KPYECKECGK AFSRSTYLGI HERTHTGEKP YECIKCGKAF RCSRVLRVHE
301 RTHSGEKPYE CKQCGKAFKY SSNLCEHERT HTGVKPYGCK ECGKSFTSSS ALRSHERTHT
361 GEKPYECKKC GKAFSCSSSL RKHERAYMWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF670 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 2.4 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 2.4 nTPM
- breast: 2.2 nTPM
- ovary: 2.2 nTPM
- endometrium: 2.1 nTPM
- testis: 2.1 nTPM
- retina: 2 nTPM
Single-cell type
- early spermatids: 4.8 nCPM
- paneth cells: 3.9 nCPM
- late primary spermatocytes: 0.9 nCPM
- late spermatids: 0.8 nCPM
- epididymal basal cells: 0.5 nCPM
- differentiating spermatogonia: 0.4 nCPM
Immune cell
- memory B-cell: 2.1 nTPM
- naive CD4 T-cell: 1.8 nTPM
- naive B-cell: 1.5 nTPM
- memory CD8 T-cell: 1.3 nTPM
- myeloid DC: 1.3 nTPM
- naive CD8 T-cell: 1.3 nTPM
Brain region
- cerebellum: 7.5 nTPM
- cerebral cortex: 4.2 nTPM
- hippocampal formation: 3.6 nTPM
- basal ganglia: 3.5 nTPM
- hypothalamus: 3.5 nTPM
- midbrain: 3.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.83
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.46
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF670 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF670 as an antibody target. Whether an autoantibody or antibody against ZNF670 could matter depends on whether native ZNF670 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF670 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF670 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...